• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Ranbaxy gets FDA approval to launch Lipitor's generic version in US

      Ranbaxy Pharmaceuticals Inc., India's largest drugmaker, announced that it has received final approval from the US Food and Drug Administration (USFDA) to launch the most sought-after generic version of Lipitor (called atorvastatin) in the US market. Lipitor is the blockbuster cholesterol-lowering drug manufactured by Pfizer Inc.

      Ranbaxy is the first company to get USFDA authorization (first-to-file status) to manufacture generic copy of the patented drug Lipitor. And Ranbaxy has been granted exclusive rights by the FDA to market atorvastatin for 180 days. With this deal, Ranbaxy could fetch millions of dollars in revenue and it is estimated that, during this period, Ranbaxy could generate profit of about $650 million.

      Lipitor is the world's top-selling anti-cholesterol drug that is widely used by millions of people to manage high cholesterol levels over time. This drug lowers bad cholesterol levels and it can raise good cholesterol levels as well. For Americans, FDA's permission to manufacture and market generic drug atorvastatin in the US comes in as an affordable alternative treatment to branded Lipitor in lowering their cholesterol levels.

       

      Share this Article!

    Back to top^